12:00 AM
May 03, 1999
 |  BC Week In Review  |  Company News  |  Other News

Dura infectious diseases news

DURA formed an acute care division to market Maxipeme cefepime and Azactam aztreonam injectable hospital anti-infectives, which...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >